Data Driven Bioscience
Data-driven biotech firm providing genomic tools for cancer diagnosis and treatment in clinical labs.
Data-driven biotech firm providing genomic tools for cancer diagnosis and treatment in clinical labs.
Founded with a mission to revolutionize cancer diagnosis and treatment, Data Driven Bioscience is a biotechnology company that provides advanced genomic tools to clinical laboratories. Their core vision is to harness the power of genomics to improve patient outcomes by enabling personalized therapy. The company's primary product, DuoSeq, facilitates the molecular identification of responders in clinical trials, thereby enhancing the precision and effectiveness of cancer treatments.
Data Driven Bioscience has garnered attention for its innovative approach to genomics in clinical settings. The company collaborates with leading researchers and clinicians to integrate their tools into practice, significantly impacting cancer treatment protocols. Notable investors and affiliations include prominent biotech venture capital firms and academic institutions. Their achievements include successful implementation of their genomic tools in multiple clinical trials, demonstrating a tangible improvement in patient response rates and reducing adverse events.
Companies similar to Data Driven Bioscience include D2G Oncology, BioSkryb Genomics, Genomenon and WhiteLab Genomics.
Data Driven Bioscience was founded in 2018.
Data Driven Bioscience's headquarters is located in Durham, NC, US.
Data Driven Bioscience's most recent funding round was for $120k (USD) in August 2018.
As of Aug 20, 2018, Data Driven Bioscience has disclosed funding of $120k (USD). Undisclosed round amounts are excluded.
Data Driven Bioscience has 30 employees as of Feb 4, 2024.
WhiteLab Genomics
whitelabgx.com
